Literature DB >> 3720531

Effect of pimozide on home cage ethanol drinking in the rat: dependence on drinking session length.

A O Pfeffer, H H Samson.   

Abstract

A stimulus-fading procedure was used to initiate ethanol drinking in free-feeding Long Evans rats. During daily half-hour drinking sessions in the home cage, a combination of sucrose and ethanol was first presented to the rats; gradually the sucrose concentration was reduced and the ethanol concentration increased until after 7 weeks the rats were drinking 10% ethanol with no sucrose. After stabilization of intake, either pimozide (PIM, 0.25, 0.50 and 1.00 mg/kg) was injected 4 h before drinking sessions or (d)-amphetamine (DEX, 0.25 and 0.50 mg/kg) was injected 15 min before sessions. The 0.50 and 1.00 mg/kg PIM doses and the 0.50 DEX dose significantly reduced intake compared to vehicle injections. In the second part of the experiment, the rats were given 24-h access to 10% ethanol and water in a two-bottle choice procedure. In this condition, 0.50 mg/kg PIM failed to reduce intake compared to vehicle. The critical difference between the two procedures seems to be that with the 30-min sessions, PIM injections were timed to have their maximal effect during testing. With 24-h sessions, decreases in intake produced by PIM could have been compensated for by increases after the drug had worn off. The hypothesis that dopamine is necessary for ethanol reinforcement receives support from the PIM effect on the 30-min sessions. The DEX effect extends the generality of our previous finding that DEX reduces ethanol-reinforced lever pressing in free-feeding rats.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3720531     DOI: 10.1016/0376-8716(86)90035-9

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  9 in total

1.  Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.

Authors:  F Weiss; M Mitchiner; F E Bloom; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Effects of dopaminergic agents on alcohol consumption by rats in a limited access paradigm.

Authors:  M A Linseman
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs.

Authors:  Hitoshi Morikawa; Richard A Morrisett
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

4.  Dorsal as well as ventral striatal lesions affect levels of intravenous cocaine and morphine self-administration in rats.

Authors:  Nobuyoshi Suto; Roy A Wise; Paul Vezina
Journal:  Neurosci Lett       Date:  2011-02-12       Impact factor: 3.046

5.  Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference.

Authors:  F O Risinger; S D Dickinson; C L Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Alcohol in excess: CRF₁ receptors in the rat and mouse VTA and DRN.

Authors:  Lara S Hwa; Joseph F Debold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

7.  Morphine induced changes in ethanol-and water-intake are attenuated by the 5-HT3/4 antagonist tropisetron (ICS 205-930).

Authors:  C W Hodge; J S Niehus; H H Samson
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

Review 8.  Ethanol and acetaldehyde action on central dopamine systems: mechanisms, modulation, and relationship to stress.

Authors:  Miriam Melis; Marco Diana; Paolo Enrico; Michela Marinelli; Mark S Brodie
Journal:  Alcohol       Date:  2009-11       Impact factor: 2.405

9.  Dopamine receptor agonists modulate voluntary alcohol intake independently of individual levels of alcohol intake in rats.

Authors:  Marcia Spoelder; Annemarie M Baars; Marthe D Rotte; Louk J M J Vanderschuren; Heidi M B Lesscher
Journal:  Psychopharmacology (Berl)       Date:  2016-05-28       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.